Clinical Trials in Pittsburgh

Showing 20301-20320 of 21,047 trials

Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics

NCT00336453

The purpose of this study was to evaluate dose-related safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine, administered to healthy children aged 6 to 59 months.

Influenza

Protein Sciences Corporation156 participantsStarted Oct 2006

Bardstown, Kentucky, United States • St Louis, Missouri, United States • Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 4< 1 mile

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

NCT00043849

The primary aim of this study is to determine the safety and efficacy of quetiapine (Seroquel) for the treatment of psychosis and/or agitation in patients with primary dementia complicated by coexistent parkinsonism, or patients with Parkinson's disease with dementia \[PDD\] who have episodes of agitation or psychosis. The secondary aim is to determine the safety and tolerability, particularly the influence on parkinsonism, of quetiapine when used to treat psychosis and/or agitation in patients with dementia complicated by coexistent parkinsonism.

DementiaParkinson Disease

National Institute on Aging (NIA)60 participantsStarted Jul 2002

Birmingham, Alabama, United States • La Jolla, California, United States • Long Beach, California, United States +18 more locations

Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

Find Trials by Condition in Pittsburgh

Memory Impairment Study (Mild Cognitive Impairment Study)

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

International Immune Tolerance Study

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)

A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

BEYOND Pilot Study

A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

Clinical Trial of Meditation for Cardiovascular Disease in Older Black Women

Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer

ABC Trial: Awakening and Breathing Controlled

TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment